VJHemOnc is committed to improving our service to you

IACH MATH 2020 | Prevention of acute GvHD

VJHemOnc is committed to improving our service to you

Florent Malard

Florent Malard, MD, PhD, Saint-Antoine Hospital, Paris, France, outlines the progress in graft-versus-host disease (GvHD) prophylaxis containing either post-transplant cyclophosphamide or anti-thymocyte globulin (ATG). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter